Cocrystal Pharma Inc (COCP) Stock Price, Quote & News

Company Profile

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a cl...

Industry: Biotechnology

Sector: Healthcare

Phone: 877 262 7123

Website: www.cocrystalpharma.com

Address:

19805 North Creek Parkway, Bothell, United States

Ron_Burn Mar. 21 at 1:06 PM

$COCP swing idea

0 · Reply

OfficialStocktwitsUser Mar. 21 at 2:51 AM

$COCP RSI: 47.62, MACD: 0.0189 Vol: 0.04, MA20: 1.05, MA50: 1.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

xDOUGx Mar. 20 at 11:12 PM

$COCP short this so momo can exit his bag that he prays will turn in something. And if you holding, take the loss and recover your money shorting it to hell

0 · Reply

xDOUGx Mar. 20 at 11:10 PM

$COCP this is going to crash, ill do my best to crash this shit stock…. Just to see momo cry. Might as well short it people

0 · Reply

xDOUGx Mar. 20 at 11:09 PM

$COCP it’s ok momo, you invest and pray for cocp… me, well I’m a master at what I do. You can’t call anything correct and spend all day looking at my profile for what? No life, no money to do something better. Once this crashes I will be reminding the world what a fool you are… and I’m pretty sure everyone else who is not your stupid account will do the same. Looking forward to it fool.

0 · Reply

resurrect_momo21 Mar. 20 at 3:07 PM

$COCP 1000% PROOF this 🤡 works on a cruise ship janitor who picks up all the noro LOL "i know coz I work for them" BUSTEDDDDDD 😭😷

0 · Reply

resurrect_momo21 Mar. 20 at 3:01 PM

$COCP this is when this loser was long before he lost all his money LOL he pumped a take over 4 years earlier LMFAO

0 · Reply

resurrect_momo21 Mar. 20 at 2:46 PM

$COCP create a lucid COIN LOL down 99% what a chump loser

0 · Reply

resurrect_momo21 Mar. 20 at 2:38 PM

$COCP curise liners are hiring how would you know dude keep shoveling the noro loser LOL LOLOL

0 · Reply

resurrect_momo21 Mar. 20 at 2:35 PM

$COCP angry psycho loser this was from 2022 - PROOF this loser cleans up noro shit and works on a cruise ship as a janitor "Im onboard" LOL

0 · Reply

First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Feb 19, 2026, 8:00 AM EST - 4 weeks ago

Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026

Dec 18, 2025, 8:00 AM EST - 3 months ago

Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus

Dec 1, 2025, 8:00 AM EST - 3 months ago

Cocrystal Pharma to Present at the Noble Capital Markets' 21st Emerging Growth Equity Conference

Nov 14, 2025, 8:00 AM EST - 4 months ago

Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Oct 30, 2025, 8:00 AM EDT - 5 months ago

Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 27, 2025, 8:00 AM EDT - 5 months ago

Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program

Oct 2, 2025, 8:00 AM EDT - 6 months ago

Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Sep 15, 2025, 4:30 PM EDT - 6 months ago

Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 12, 2025, 9:43 AM EDT - 6 months ago

Cocrystal Pharma, Inc. Announces Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 12, 2025, 8:00 AM EDT - 6 months ago

Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference

Sep 8, 2025, 8:00 AM EDT - 6 months ago

Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment

Sep 3, 2025, 8:00 AM EDT - 7 months ago

Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference

Aug 14, 2025, 8:00 AM EDT - 7 months ago

Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Aug 5, 2025, 8:00 AM EDT - 8 months ago

Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference

Jul 10, 2025, 8:00 AM EDT - 9 months ago

Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference

Jun 5, 2025, 8:00 AM EDT - 10 months ago

Cocrystal Pharma's Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference

May 29, 2025, 8:00 AM EDT - 10 months ago

Cocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain

May 28, 2025, 8:00 AM EDT - 10 months ago

Cocrystal Pharma to Participate in Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference

May 15, 2025, 8:00 AM EDT - 11 months ago

Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Apr 24, 2025, 8:00 AM EDT - 11 months ago

Cocrystal Pharma's Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Mar 6, 2025, 8:00 AM EST - 1 year ago

Cocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025

Dec 31, 2024, 2:21 PM EST - 1 year ago

Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide

Dec 31, 2024, 8:00 AM EST - 1 year ago

Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344

Aug 19, 2024, 4:05 PM EDT - 1 year ago

Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences

Aug 15, 2024, 3:00 PM EDT - 1 year ago

CoCrystal Pharma to Present at August 20th Virtual Investor Summit Microcap Event

May 13, 2024, 8:00 AM EDT - 2 years ago

Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

May 1, 2024, 8:00 AM EDT - 2 years ago

Enrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza

Mar 28, 2024, 8:00 AM EDT - 2 years ago

Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Mar 19, 2024, 8:00 AM EDT - 2 years ago

Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A

Mar 5, 2024, 8:30 AM EST - 2 years ago

Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap

Dec 6, 2023, 8:00 AM EST - 2 years ago

Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A

Nov 29, 2023, 8:00 AM EST - 2 years ago

Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

Nov 27, 2023, 8:00 AM EST - 2 years ago

Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023

Nov 9, 2023, 8:00 AM EST - 2 years ago

Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast

Oct 31, 2023, 8:00 AM EDT - 2 years ago

Cocrystal Pharma Receives UK MHRA Authorization to Initiate Its Phase 2a Influenza Human Challenge Trial with Oral PB2 Inhibitor CC-42344

Sep 5, 2023, 8:00 AM EDT - 2 years ago

Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference

Apr 10, 2023, 8:30 AM EDT - 3 years ago

Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Mar 22, 2023, 8:00 AM EDT - 3 years ago

Cocrystal Pharma to Highlights Progress with Its Antiviral Portfolio at the Virtual Investor Summit on March 29, 2023

Jan 26, 2023, 8:00 AM EST - 3 years ago

Cocrystal Pharma Announces Participation in Virtual Investor Events

Jan 23, 2023, 9:00 AM EST - 3 years ago

Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast

Dec 1, 2022, 4:05 PM EST - 3 years ago

Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022

Nov 17, 2022, 8:00 AM EST - 3 years ago

Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A

Nov 1, 2022, 4:05 PM EDT - 3 years ago

Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza

Oct 26, 2022, 8:00 AM EDT - 3 years ago

Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344

Oct 5, 2022, 8:00 AM EDT - 3 years ago

Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference

Oct 3, 2022, 4:05 PM EDT - 3 years ago

Cocrystal Pharma Announces a 1-for-12 Reverse Stock Split

Aug 8, 2022, 8:00 AM EDT - 3 years ago

Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344

Ron_Burn Mar. 21 at 1:06 PM

$COCP swing idea

0 · Reply

OfficialStocktwitsUser Mar. 21 at 2:51 AM

0 · Reply

xDOUGx Mar. 20 at 11:12 PM

$COCP short this so momo can exit his bag that he prays will turn in something. And if you holding, take the loss and recover your money shorting it to hell

0 · Reply

xDOUGx Mar. 20 at 11:10 PM

$COCP this is going to crash, ill do my best to crash this shit stock…. Just to see momo cry. Might as well short it people

0 · Reply

xDOUGx Mar. 20 at 11:09 PM

0 · Reply

resurrect_momo21 Mar. 20 at 3:07 PM

$COCP 1000% PROOF this 🤡 works on a cruise ship janitor who picks up all the noro LOL "i know coz I work for them" BUSTEDDDDDD 😭😷

0 · Reply

resurrect_momo21 Mar. 20 at 3:01 PM

$COCP this is when this loser was long before he lost all his money LOL he pumped a take over 4 years earlier LMFAO

0 · Reply

resurrect_momo21 Mar. 20 at 2:46 PM

$COCP create a lucid COIN LOL down 99% what a chump loser

0 · Reply

resurrect_momo21 Mar. 20 at 2:38 PM

$COCP curise liners are hiring how would you know dude keep shoveling the noro loser LOL LOLOL

0 · Reply

resurrect_momo21 Mar. 20 at 2:35 PM

$COCP angry psycho loser this was from 2022 - PROOF this loser cleans up noro shit and works on a cruise ship as a janitor "Im onboard" LOL

0 · Reply

resurrect_momo21 Mar. 20 at 1:58 PM

$COCP Angry low life trash sniverling broke loser the best is when he disapears when boom boom momo takes over and don't believe me read his 5 yrs on ST account LOL childs play

0 · Reply

xDOUGx Mar. 20 at 12:40 AM

$COCP whahaha, you got nothing to say about this shit stock, all you do is think about me. Cocp is going to shit and I will continue feasting on you lose. You useless trader… don’t worry you will be where you belong sooner rather than later.

0 · Reply

resurrect_momo21 Mar. 19 at 1:45 PM

$COCP with his lucid i am am loser 5000 posts 10 accts 2 still left down 99% t shirts unsold is the only bear left who pretends who has a massive short shares LOL low life you broke loser

0 · Reply

xDOUGx Mar. 18 at 6:58 PM

$COCP as I say it is

0 · Reply

xDOUGx Mar. 18 at 6:51 PM

$COCP oh wait… pumped with 5 share buys…. Nevermind it’s coming down now

0 · Reply

xDOUGx Mar. 18 at 6:48 PM

$COCP I’ll just add bitch

1 · Reply

resurrect_momo21 Mar. 18 at 6:22 PM

$COCP the only thing dropping is all the noro💩 you clean up on the cruise ship as one of the janitors loser broke dirt bag already starting to freak at least wait until 10 loser

0 · Reply

Ricob809 Mar. 18 at 6:02 PM

$COCP already up 15% and i got in less than a month ago. Nice!

0 · Reply

xDOUGx Mar. 18 at 5:48 PM

$COCP lol, fuck you… it will drop, no need to worry about a thing

0 · Reply

Usually_Im_Right Mar. 18 at 3:43 PM

$COCP send it higher 🚀

0 · Reply

resurrect_momo21 Mar. 18 at 2:01 PM

$COCP Momo boom boom is coming $50 before June I can feel it oh yeahhhhh

0 · Reply

xDOUGx Mar. 17 at 11:38 PM

$COCP down down we go… you have been slapping this stock for years now, come on, how far down are you… tell us, whahahaha

0 · Reply

Market Cap	15.58M
Revenue (ttm)	0.00
Net Income (ttm)	-17.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	49,100
Avg Vol	64,882
Day's Range	N/A - N/A
Shares Out	13.78M
Stochastic %K	19%
Beta	1.18
Analysts	Strong Sell
Price Target	$6.67